ARSENALBIO
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981124
- Registration number
- 7580387
- Mark type
- Stylized text
- Filed
- 26 Mar 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 26 Nov 2024
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions
Owner
- Arsenal Biosciences, Inc., South San Francisco, CA, US
- Arsenal Biosciences, Inc., South San Francisco, CA, US
- Arsenal Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 03 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Aug 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 09 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Mar 2024 — USE AMENDMENT FILED
- 27 Jun 2024 — SOU EXTENSION 5 GRANTED
- 01 Mar 2024 — SOU EXTENSION 5 FILED